Hydronidone clinical trials
How each study uses hydronidone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the hydronidone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
15 studies that test it; most in 2026 (6)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2019 | 3 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 3 |
| 2026 | 6 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 15 · Other 0
Beijing Continent Pharmaceutical Co, Ltd. (14) · Shanghai Genomics, Inc. (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test hydronidone.
- Dec 2026A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal InsufficiencyPhase 1 · Beijing Continent Pharmaceutical Co, Ltd.
Studies
Open first, then newest update. How each study uses hydronidone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 15
- A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal InsufficiencyRecruitingPhase 1Beijing Continent Pharmaceutical Co, Ltd.NCT07262333Written as Hydronidone capsules
- A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B.Not yet recruitingPhase 3Beijing Continent Pharmaceutical Co, Ltd.NCT07412236Written as Hydronidone (270mg)
- Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver FibrosisRecruitingPhase 3Beijing Continent Pharmaceutical Co, Ltd.NCT05905172Written as Hydronidone capsules
- The Phase Ⅰd Clinical Trial of Hydronidone CapsulesCompletedPhase 1Beijing Continent Pharmaceutical Co, Ltd.NCT07262346Written as Hydronidone capsules
- [¹⁴C] Hydronidone Mass Balance StudyCompletedPhase 1Beijing Continent Pharmaceutical Co, Ltd.NCT07471217Written as [¹⁴C]Hydronidone
- Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy ControlsCompletedPhase 1Beijing Continent Pharmaceutical Co, Ltd.NCT07394309Written as Hydronidone capsules
- A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver CirrhosisCompletedPhase 3Beijing Continent Pharmaceutical Co, Ltd.NCT07343778Written as Hydronidone Capsules
- QTc Assessment in a Single-Dose Study of Hydronidone CapsulesCompletedPhase 1Beijing Continent Pharmaceutical Co, Ltd.NCT07263152Written as Hydronidone
- A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver FibrosisCompletedPhase 2Beijing Continent Pharmaceutical Co, Ltd.NCT07417553Written as Hydronidone capsules
- A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver FibrosisCompletedPhase 2Beijing Continent Pharmaceutical Co, Ltd.NCT07364448Written as Hydronidone capsules
- Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.CompletedPhase 3Beijing Continent Pharmaceutical Co, Ltd.NCT05115942Written as Hydronidone capsules
- A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic HepatitisCompletedPhase 2Shanghai Genomics, Inc.NCT02499562Written as Hydronidone
- Study on PK of Hydronidone in Patients and Special PopulationCompletedPhase 1Beijing Continent Pharmaceutical Co, Ltd.NCT04123769Written as Hydronidone
- Study on Pharmacokinetics of HydronidoneCompletedPhase 1Beijing Continent Pharmaceutical Co, Ltd.NCT04162821Written as Hydronidone
- Study on Hydronidone Capsule BECompletedNot applicableBeijing Continent Pharmaceutical Co, Ltd.NCT04125056Written as Hydronidone Capsule(Specification: 30 mg / grain)
Codes
What other systems call hydronidone · ClinicalTrials.gg INT000766
- MeSH (NLM) C000621986hydronidoneOne source ClinicalTrials.gov
- Wikidata Q27288328hydronidoneOne source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000621986 | hydronidone | One source ClinicalTrials.gov |
| Wikidata | Q27288328 | hydronidone | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.